检索结果-南通市图书馆

台湾研究 2024年第1期 1-14页

作者： Institute of Taiwan Studies, chinese academy of Social Sciences 中国社会科学院台湾研究所

2024年1月13日,台湾地区领导人和立法机构“二合一”选举落下幕。民进党籍候选人赖清德、萧美琴当选台湾地区正副领导人。台湾地区立法机构总额113席中,中国国民党获52席,民进党获51席,民众党获8席,无党籍及未经政党推荐者获2席.

关键词：中国国民党民进党立法机构台湾地区民众党推荐者二合一候选人

Effect of Sprinkler Irrigation on Crop’s Growth

在线全文

学校读者我要写书评

暂无评论

Effect of Sprinkler Irrigation on Crop’s Growth

Life Science:Innovation and prosperity—commemorating the 60th anniversary of the chinese academy of Sciences

国际农业工程大会

作者： Yaohu Kang Haijun Liu Sumei Yao Shiping LiuKey Lab of Water Cycle & Related Land Surface Processes Institute of Geographic Sciences and Natural Resources Research chinese academy of sciencesm Datun Road Anwai Beijing 100101 China.Wei LiuNingxia Office of Integrated Agricultural Development Porject North street of Jinning 7# Yinchuan City Ningxia 750001 China

＜正＞ A three-year experiment was carried out to investigate the effect of sprinkler irrigation on winter wheat growth in North China Plain. The surface irrigation was arranged as control. The research results indicate that: （1） amplitude of soil moisture during irrigation intervals under sprinkler irrigation condition was lower than that under surface irrigation condition;（2） the maximum number of tillers under sprinkler irrigation condition was smaller than that

关键词：

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Science China(Life Sciences) 2010年第1期53卷 2-12页

作者： LI JiaYang chinese academy of Sciences,52 Sanlihe Road,Beijing 100864,China chinese academy of Sciences

In tandem with the birth and growth of the People’s Republic of China (PRC),the chinese academy of Sciences (CAS) passed through six decades by the year of 2009.

关键词： commemorating the 60 Life Science anniversary of the chinese academy of Sciences th Innovation

Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors(2024)

在线全文

学校读者我要写书评

暂无评论

chinese Journal of Cancer Research 2024年第3期36卷 240-256页

作者： Zaiwei Song Dan Jiang Lingling Yu Yixuan Chen Daobin Zhou Yue Li Depei Wu Lingli Zhang Liyan Miao Jun Ma Jun Zhu Hongmei Jing Rongsheng Zhao the Steering Committee,the Consensus Panel and the Evidence Synthesis Group Evidence-based Pharmacy Professional Committee of chinese Pharmaceutical Association(CPA) Hospital Pharmacy Professional Committee of chinese Pharmaceutical Association(CPA) Division of Therapeutic Drug Monitoring of chinese Pharmacological Society(CPS) Expert Committee on Lymphoma of chinese Society of Clinical Oncology(CSCO) Expert Committee on Leukemia of chinese Society of Clinical Oncology(CSCO) Society of Integrative Cardio-Oncology of China Anti-Cancer Association(CACA) chinese Society of Hematology of chinese Medical Association(CMA) Hospital Pharmacy Professional Committee of Cross-Straits Medicine Exchange Association(SMEA) Department of Pharmacy Peking University Third HospitalBeijing 100191China Institute for Drug Evaluation Peking University Health Science CenterBeijing 100191China Therapeutic Drug Monitoring and Clinical Toxicology Center Peking UniversityBeijing 100191China Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical SciencesPeking UniversityBeijing 100191China Department of Hematology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100005China Department of Cardiology the First Affiliated HospitalHarbin Medical UniversityHarbin 150001China Department of Hematology the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Pharmacy Evidence-based Pharmacy CenterWest China Second HospitalSichuan UniversityChengdu 610041China Department of Pharmacy the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Hematology and Oncology Harbin Institute of Hematology and OncologyHarbin 150010China Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Department of LymphomaPeking University Cancer Hospital&InstituteBeijing 100142China Department of Hematology Peking University Third HospitalBeijing 100191China 不详

Bruton’s tyrosine kinase inhibitors(BTKis)have revolutionized the treatment of B-cell ***,safety issues related to the use of BTKis may hinder treatment continuity and further affect clinical efficacy.A comprehensive and systematic expert consensus from a pharmacological perspective is lacking for safety issues associated with BTKi treatment.A multidisciplinary consensus working group was established,comprising 35 members from the fields of hematology,cardiovascular disease,cardio-oncology,clinical pharmacy,and evidencebased *** evidence-based expert consensus was formulated using an evidence-based approach and the Delphi *** Joanna Briggs Institute Critical Appraisal(JBI)tool and Grading of Recommendations Assessment,Development,and Evaluation(GRADE)approach were used to rate the quality of evidence and grade the strength of recommendations,*** consensus provides practical recommendations for BTKis medication based on nine aspects within three domains,including the management of common adverse drug events such as bleeding,cardiovascular events,and hematological toxicity,as well as the management of drug-drug interactions and guidance for special *** multidisciplinary expert consensus could contribute to promoting a multi-dimensional,comprehensive and standardized management of BTKis.

关键词： Consensus BTK inhibitors safety adverse drug events drug-drug interactions

Meet Our New Associate Editors

在线全文

学校读者我要写书评

暂无评论

chinese Journal of Chemistry 2024年第11期42卷 1319-1321页

作者： Editorial Office of chinese Journal of Chemistry 不详

Associate Editor Dehui Deng Professor The State Key Laboratory of Catalysis Dalian Institute of Chemical Physics,chinese academy of Sciences,China(+86)0411-82463870,dhdeng@***,https:/***/.Education:2003-2007 B.S.,Light Industry Engineering and National Economy Management,Sichuan University.2007-2013 Ph.D.,Physical Chemistry,Dalian Institute of Chemical Physics,chinese academy of Sciences(Supervisor:*** Bao and *** Pan).

关键词： Dalian Economy Associate

The Development of Library and Information Profession in the chinese academy of Sciences

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

图书情报工作 1996年第1期 5-11页

作者： Meng GuangjunWang Bing (Documentation and Information Center, the chinese academy of Sciences)

The infrastructure of the library and information system of the chinese academy of Sciences is introduced, library and information service, and the applications of information technology are studied. The academic acti... 详细信息

关键词： chinese academy of Sciences\ library and information profession\ China

中国科学院青岛生物能源与过程研究所2023年度“十大工作进展”

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

高科技与产业化 2024年第9期30卷 20-23页

作者： Qingdao Institute of Bioenergy and Process, chinese academy of Sciences 中国科学院青岛生物能源与过程研究所

2023年,中国科学院青岛生物能源与过程研究所驰骋奋发、勇毅前行,紧紧围绕“四个率先”和“两加快一努力”的目标要求,进一步强化国家战略科技力量主力军使命担当,共同绘就了研究所繁荣发展的辉煌历程,各项事业取得可喜进展。

关键词：中国科学院生物能源工作进展使命担当研究所主力军辉煌历程青岛

Stress Echocardiography for Chronic Coronary Syndrome:Clinical Practice Guidelines(2023)

在线全文

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第5期21卷 475-505页

作者： Peng-Fei ZHANG Jia-Wei TIAN Tian-Gang ZHU Jue-Fei WU Xiao-Ping LENG Yi WANG Meng-Meng LI Xin-Hao LI Qian-Qian WANG Xiao-Peng FENG Jia-Yan LV Li-Xue YIN Yun ZHANG Mei ZHANG chinese Society of Echocardiography,Superficial Tissue and Vascular Group of chinese Society of Ultrasound in Medicine,Ultrasound Professional Committee of chinese Medicine Education Association State Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function ResearchChinese Ministry of EducationChinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChina The Second Affiliated Hospital of Harbin Medical University HaerbinChina Peking University People's Hospital BeijingChina Sichuan Province People's Hospital ChengduChina Nanfang Hospital Southern Medical UniversityGuangzhouChina Peking Union Medical College Hospital Chinese Academy of Medical SciencesBeijingChina 不详

In the context of the People's Republic of China,coronary artery disease(CAD)presents a sig-nificant clinical challenge,with over 11.3 mil-lion patients ***,the diagnos-is of CAD has predominantly relied on invasive coronary angiography.[1]However,recent advances in clinical research have revealed a notable trend:a substantial 82% of patients subjected to such invas-ive diagnostics do not necessitate interventional therapy.

关键词： coronary clinical patients

chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer

在线全文

学校读者我要写书评

暂无评论

中华医学杂志(英文版) 2024年第17期137卷 2017-2039页

作者： Li Jingnan Yao Hongwei Lu Yun Zhang Shutian Zhang Zhongtao Society of Digestive Endoscopy of the chinese Medical Association Colorectal Surgery Group of the chinese Medical Association chinese Association of Gastroenterologist & Hepatologist National Clinical Research Center for Digestive Diseases chinese Medical Journal Clinical Practie Guideline Collaborative Department of Gastroenterology Peking Union Medical College Hospital Chinese Academy of Medical Sciences Peking Union Medical College Beijing China Department of General Surgery Beijing Friendship Hospital Capital Medical University National Clinical Research Center for Digestive Diseases Beijing China Department of General Surgery The Affiliated Hospital of Qingdao University Qingdao Shandong China Department of Gastroenterology Beijing Friendship Hospital Capital Medical University National Clinical Research Center for Digestive Disease Beijing China

Background: The incidence and mortality of colorectal cancer (CRC) in China are increasing in recent years. The clarified pathogenesis and detectable precancerous lesions of CRC make it possible to prevent, screen, and diagnose CRC at an early stage. With the development of endoscopic and surgical techniques, the choice of treatment for early CRC is also worth further discussion, and accordingly, a standard follow-up program after treatment needs to be ***: This clinical practice guideline (CPG) was developed following the recommended process of the World Health Organization, adopting Grading of Recommendations Assessment, Development and Evaluation (GRADE) in assessing evidence quality, and using the Evidence to Decision framework to formulate clinical recommendations, thereby minimizing bias and increasing transparency of the CPG development process. We used the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement and Appraisal of Guidelines for Research and Evaluation II (AGREE II) as reporting and conduct guides to ensure the guideline’s completeness and ***: This CPG comprises 46 recommendations concerning prevention, screening, diagnosis, treatment, and surveillance of CRC. In these recommendations, we have indicated protective and risk factors for CRC and made recommendations for chemoprevention. We proposed a suitable screening program for CRC based on the chinese context. We also provided normative statements for the diagnosis, treatment, and surveillance of CRC based on existing clinical evidence and ***: The 46 recommendations in this CPG are formed with consideration for stakeholders’ values and preferences, feasibility, and acceptability. Recommendations are generalizable to resource-limited settings with similar CRC epidemiology pattern as China.

关键词： Colorectal cancer Early detection of cancer Prevention Screening Diagnosis Treatment Follow-up Guideline

Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Infectious Diseases & Immunity 2024年第3期4卷 106-120页

作者： chinese Society of Infectious Diseases chinese Medical Association chinese Society of Hepatology chinese Medical Association Group of Infectious Diseases chinese Pediatric Society chinese Medical Association National Clinical Research Center for Infectious Diseases(Beijing) Fu-Sheng Wang Shishu Zhu Min Zhang Jianshe Wang Shuangjie Li Junliang Fu Yuanyuan Li Yuming Guo Jing Li Hongmei Xu Wenxian Ouyang Yuemin Nan Sainan Shu Shuangsuo Dang Xiaoyuan Xu Taisheng Li Jinlin Hou 不详 The Fifth Medical Center of PLA General Hospital Beijing 100039China Fudan University Children’s Hospital Hunan Children’s Hospital Children’s Hospital of Chongqing Medical University Third Hospital Hebei Medical University Tongji Hospital Tongji Medical CollegeHuazhong University of Science and Technology The Second Affiliated Hospital of Xi’an Jiaotong University Peking University First Hospital Peking Union Medical College Hospital Chinese Academy of Medical Sciences&Peking Union Medical College Nanfang Hospital Southern Medical University

The aim of this consensus is to standardize the prevention, diagnosis, and treatment of chronic hepatitis B in children and to achieve the goal of “eliminating viral hepatitis as a major public health threat by 2030” issued by the World Health Organization. Formulated by organized experts of the chinese Society of Infectious Diseases and chinese Society of Hepatology, chinese Medical Association;Group of Infectious Diseases, chinese Pediatric Society, chinese Medical Association;and the National Clinical Research Center for Infectious Diseases (Beijing), the consensus provides the latest evidence and recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B in children.

关键词： Chronic hepatitis B Children Treatment Prevention Consensus